![]()
|
|
||||||||
J. Biol. Chem., Vol. 278, Issue 47, 46541-46548, November 21, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
B
Increases NF-
B-independent Transcription through Binding to Histone Deacetylase (HDAC) 1 and HDAC3*





||




||**
From the
Laboratory of Medical Chemistry and Human Genetics and the
Laboratory of Virology and Immunology, Center for Cellular and Molecular Therapy, University of Liège, Sart-Tilman, 4000 Liège, Belgium, and the ¶Laboratory of Molecular Virology, Department of Biological Chemistry, Institute of Biological and Molecular Medicine, Free University of Brussels, 6041 Gosselies, Belgium
I
B
is an inhibitory molecule that sequesters NF-
B dimers in the cytoplasm of unstimulated cells. Upon stimulation, NF-
B moves to the nucleus and induces the expression of a variety of genes including I
B
. This newly synthesized I
B
also translocates to the nucleus, removes activated NF-
B from its target genes, and brings it back to the cytoplasm to terminate the phase of NF-
B activation. We show here that I
B
enhances the transactivation potential of several homeodomain-containing proteins such as HOXB7 and Pit-1 through a NF-
B-independent association with histone deacetylase (HDAC) 1 and HDAC3 but not with HDAC2, -4, -5, and -6. I
B
bound both HDAC proteins through its ankyrin repeats, and this interaction was disrupted by p65. Immunofluorescence experiments demonstrated further that I
B
acts by partially redirecting HDAC3 to the cytoplasm. At the same time, an I
B
mutant, which lacked a functional nuclear localization sequence, interacted very efficiently with HDAC1 and -3 and intensively enhanced the transactivation potential of Pit-1. Our results support the hypothesis that the NF-
B inhibitor I
B
regulates the transcriptional activity of homeodomain-containing proteins positively through cytoplasmic sequestration of HDAC1 and HDAC3, a mechanism that would assign a new and unexpected role to I
B
.
Received for publication, June 17, 2003 , and in revised form, August 29, 2003.
* This work was supported by grants from the National Fund for Scientific Research, Belgium (F.N.R.S.) and TELEVIE and by the Belgian "Centre Anti-Cancéreux" (Ulg). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Part of a PAI (Pôle d'attraction inter-universitaire).
|| Research Associate at the F.N.R.S.
** To whom correspondence should be addressed: Laboratory of Medical Chemistry/CTCM, Pathology, +3 B23, C.H.U. Sart-Tilman, University of Liège, 4000 Liège, Belgium. Tel.: 32-4-366-24-86; Fax: 32-4-366-45-34; E-mail: Alain.chariot{at}ulg.ac.be.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
O. Kwon, K. A Kim, S. O. Kim, R. Ha, W. K. Oh, M. S. Kim, H. S. Kim, G. D. Kim, J. W. Kim, M. Jung, et al. NF-{kappa}B inhibition increases chemosensitivity to trichostatin A-induced cell death of Ki-Ras-transformed human prostate epithelial cells Carcinogenesis, November 1, 2006; 27(11): 2258 - 2268. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ma, J. Li, I. Chiu, Y. Wang, J. A. Sloane, J. Lu, B. Kosaras, R. L. Sidman, J. J. Volpe, and T. Vartanian Toll-like receptor 8 functions as a negative regulator of neurite outgrowth and inducer of neuronal apoptosis J. Cell Biol., October 23, 2006; 175(2): 209 - 215. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Gao, Q. He, B. Peng, P. J. Chiao, and J. Ye Regulation of Nuclear Translocation of HDAC3 by I{kappa}B{alpha} Is Required for Tumor Necrosis Factor Inhibition of Peroxisome Proliferator-activated Receptor {gamma} Function J. Biol. Chem., February 17, 2006; 281(7): 4540 - 4547. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Aguilera, R. Hoya-Arias, G. Haegeman, L. Espinosa, and A. Bigas Recruitment of I{kappa}B{alpha} to the hes1 promoter is associated with transcriptional repression PNAS, November 23, 2004; 101(47): 16537 - 16542. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Hanson, N. A. Hawke, D. Kashatus, and A. S. Baldwin The Nuclear Factor {kappa}B Subunits RelA/p65 and c-Rel Potentiate but Are Not Required for Ras-Induced Cellular Transformation Cancer Res., October 15, 2004; 64(20): 7248 - 7255. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. V. Guseva, A. F. Taghiyev, M. T. Sturm, O. W. Rokhlin, and M. B. Cohen Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Mediated Activation of Mitochondria-Associated Nuclear Factor-{kappa}B in Prostatic Carcinoma Cell Lines Mol. Cancer Res., October 1, 2004; 2(10): 574 - 584. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. G. Cosio, L. Tsaprouni, K. Ito, E. Jazrawi, I. M. Adcock, and P. J. Barnes Theophylline Restores Histone Deacetylase Activity and Steroid Responses in COPD Macrophages J. Exp. Med., September 7, 2004; 200(5): 689 - 695. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ajenjo, E. Canon, I. Sanchez-Perez, D. Matallanas, J. Leon, R. Perona, and P. Crespo Subcellular Localization Determines the Protective Effects of Activated ERK2 against Distinct Apoptogenic Stimuli in Myeloid Leukemia Cells J. Biol. Chem., July 30, 2004; 279(31): 32813 - 32823. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |